Synergy CHC Corp. Gain (Loss) on Extinguishment of Debt
Synergy CHC Corp. (SNYR) reported Gain (Loss) on Extinguishment of Debt of $2.15 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-04-01
- Synergy CHC Corp. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was $0.00.
- Synergy CHC Corp. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- Synergy CHC Corp. gain (loss) on extinguishment of debt for fiscal 2025 was $2.15M.
- Synergy CHC Corp. gain (loss) on extinguishment of debt for fiscal 2016 was -$657.18K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $0.00 derived: sum of 2 quarters · filed 2026-04-01 | $2.15M 10-K · filed 2026-04-01 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.15M 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $2.15M 10-Q · filed 2025-08-14 | ||||
| 2016-12-31 | -$657.18K 10-K · filed 2018-04-02 | $657.18K 10-K · filed 2017-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |